-
-
Call more information
660-596-2224 -
SmartTots Releases Updated Consensus Statement Regarding Anesthesia Safety in Young Children Health experts say growing evidence points to need for more research; urge caution but not alarm San Francisco, CA (October 13, 2015) SmartTots today released an updated consensus statement that emphasizes a need for more research into the safety of anesthetics and sedatives administered to infants and […]
Read MoreIn patients with low back pain, early physical therapy does not lead to clinically meaningful improvements in disability or pain, a JAMA study finds. The study included some 200 adults seen in primary care with low back pain of less than 16 days’ duration, with a disability score of 20 or higher (on a 100-point scale), and […]
Read MoreAuthors: Susan Curling, M.D., M.B.A. ASA Monitor 10 2015, Vol.79, 18-19. Susan Curling, M.D., M.B.A., is former Medical Director for Quality, Memorial Hermann Hospital Northeast, Humble, Texas. The core goal of leadership is to develop an inspired culture that changes a job into a calling. Several physician anesthesiologists have been instrumental in accomplishing this goal. In a […]
Read MoreAuthors: Nicholas M. Halzack, M.P.H. et al ASA Monitor 10 2015, Vol.79, 10-12. The relationship between surgical volume and patient outcomes has been studied extensively since the 1980s. The “volume” variable is often measured in two ways: hospital volume (the amount of surgeries the hospital performs) and surgeon volume (the amount of surgeries each surgeon performs). So, […]
Read MoreThe US Food and Drug Administration (FDA) has granted accelerated approval to Praxbind (idarucizumab, Boehringer Ingelheim) to rapidly reverse the blood-thinning effects of the anticoagulant Pradaxa (dabigatran, Boehringer Ingelheim). “The anticoagulant effects of Pradaxa are important and life-saving for some patients, but there are situations where reversal of the drug’s effects is medically necessary,” said […]
Read MoreA perspective in the New England Journal of Medicine discusses the FDA’s risk assessment of serious neurologic events associated with the off-label use of epidural glucocorticoid injections. In April 2014, the FDA required a label change for injectable corticosteroids — which are commonly used to treat neck and back pain — to warn about “rare but serious,” […]
Read MoreAuthors: Hassan Farhan, M.D. et al Anesthesiology 10 2015. Abstract Muscle weakness is common in the surgical intensive care unit (ICU). Low muscle mass at ICU admission is a significant predictor of adverse outcomes. The consequences of ICU-acquired muscle weakness depend on the underlying mechanism. Temporary drug-induced weakness when properly managed may not affect outcome. Severe […]
Read MorePatients undergoing bariatric surgery show a small but definite increase in self-harm emergencies after the procedure, researchers report in JAMA Surgery. Using Ontario provincial health records, the researchers compared rates of self-harm incidents in the 3 years preceding surgery versus the 3 years following it in some 8800 patients. Self-harm was measured as emergency visits for […]
Read MoreRegional Anesthesia & Pain Medicine: July/August 2015 – Volume 40 – Issue 4 – p 315–320 Authors: Tiyaprasertkul, Worakamol MD Background and Objectives: This prospective randomized trial compared ultrasound-guided single-injection (SI) and triple-injection (TI) subparaneural popliteal sciatic nerve block. We hypothesized that multiple injections are not required when local anesthetic (LA) is deposited under the […]
Read MoreAuthors: Ajay D. Wasan, M.D., M.Sc. et al Anesthesiology 10 2015, Vol.123, 861-872. Background: Opioids are frequently prescribed for chronic low back pain (CLBP), but there are little prospective data on which patient subgroups may benefit. Psychiatric comorbidity, such as high levels of depression and anxiety symptoms (termed comorbid negative affect [NA]), is a common presentation and […]
Read More